当前位置:首页 > 文献互助 > 互助详情

IN10028, a next-generation FAK inhibitor discovered for the treatment of solid tumors复制

用户k6K1hVf-lRio 39分钟前 10 10 已关闭

DOI:复制

文献链接: https://doi.org/10.1158/1538-7445.AM2026-5867复制

其他信息:

B Zhang, H Wang, J Gao, F Xi, L Liu, L Liu…
Cancer …, 2026
aacrjournals.org
The development of small-molecule inhibitors targeting Focal Adhesion Kinase (FAK) has been ongoing for several decades. In May 2025, the FDA approved a combination therapy involving FAK and MEK/RAF inhibitors for the treatment of low-grade serous ovarian cancer, marking a significant advancement in FAK-targeted therapies. In this study, we present IN10028, a second-generation FAK inhibitor that demonstrates enhanced efficacy in combination therapies and favorable safety profiles. IN10028 effectively targets both FAK1 …

互助时间线

2026-08-24 16:05:44 [关闭求助]

系统关闭了求助

备注: 显示free已经是全文了 没有下载选项 直接看网页哦

2026-08-24 15:46:08 [发起求助]